Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 3:54 PM UTC
| NCT Number | NCT07190248 |
| Recruiting Status | Recruiting |
| Condition | Non-small Cell Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 675 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | August 28, 2026 (Yesterday) |
As of August 29, 2026: Clinical trial NCT07190248 is currently recruiting participants. This phase3 study for non-small cell lung cancer is actively seeking new participants at 12 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07190248 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07190248 was last updated Yesterday (August 28, 2026). HelloStudys verifies this status automatically.